Ian F. Harrison

2.6k citations

36 papers · 1.8k indexed · 1 hit paper · h-index 20

Cellular and Molecular Neuroscience top 2%
Neurology top 2%
Radiology, Nuclear Medicine and Imaging top 5%
Molecular Biology
Physiology top 10%

Co-authors: David T. Dexter Mark F. Lythgoe Jack A. Wells Ozama Ismail Yolanda Ohene Payam Nahavandi Tracey K. Murray Michael J. O’Neill
Topics: Advanced Neuroimaging Techniques and Applications (13 papers)Alzheimer's disease research and treatments (11 papers)Cerebrospinal fluid and hydrocephalus (11 papers)
Cited by: Cellular and Molecular Neuroscience Neurology
Journals: Nature Communications PLoS ONE NeuroImage
Partner nations: United Kingdom United States Canada

In The Last Decade

Ian F. Harrison

36 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model

2020 403 citations Ian F. Harrison, Ozama Ismail et al. Brain profile →

Peers

Countries citing papers authored by Ian F. Harrison

Since Specialization

Citations

This map shows the geographic impact of Ian F. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian F. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian F. Harrison more than expected).

Fields of papers citing papers by Ian F. Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian F. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian F. Harrison. The network helps show where Ian F. Harrison may publish in the future.

Co-authorship network of co-authors of Ian F. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Ian F. Harrison. A scholar is included among the top collaborators of Ian F. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian F. Harrison. Ian F. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The influence of the glymphatic system on α-synuclein propagation: the role of aquaporin-4 2025 ·Brain ·Douglas M. Lopes,(unknown),(unknown),(unknown),Jack A. Wells,Matthew E. Gegg,Guglielmo Verona,Mark F. Lythgoe,Ian F. Harrison	1
2	Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model 2024 ·Alzheimer s Research & Therapy ·Douglas M. Lopes,Jack A. Wells,Da Ma,L. I. Wallis,Daniel Park,(unknown),Zeshan Ahmed,Mark F. Lythgoe,Ian F. Harrison	14
3	Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system 2022 ·Translational Neurodegeneration ·Douglas M. Lopes,(unknown),Ian F. Harrison	45
4	Pharmacological MRI with Simultaneous Measurement of Cerebral Perfusion and Blood-Cerebrospinal Fluid Barrier Function using Interleaved Echo-Time Arterial Spin Labelling 2021 ·NeuroImage ·(unknown),Ian F. Harrison,Mark F. Lythgoe,David L. Thomas,Jack A. Wells	12
5	People with Parkinson’s Disease: What Symptoms Do They Most Want to Improve and How Does This Change with Disease Duration? 2021 ·Journal of Parkinson s Disease ·(unknown),Martin G. Rumsby,(unknown),Ian F. Harrison,(unknown),(unknown)	48
6	Substantially thinner internal granular layer and reduced molecular layer surface in the cerebellar cortex of the Tc1 mouse model of down syndrome – a comprehensive morphometric analysis with active staining contrast-enhanced MRI 2020 ·NeuroImage ·Da Ma,M. Jorge Cardoso,María A. Zuluaga,Marc Modat,Nick Powell,Frances K. Wiseman,Jon O. Cleary,Benjamin Sinclair,Ian F. Harrison,Bernard Siow,Karteek Popuri,Sieun Lee,Joanne A. Matsubara,Marinko V. Šarunic,Mirza Faisal Beg,Victor L. J. Tybulewicz,Elizabeth Fisher,Mark F. Lythgoe,Sébastien Ourselin	4
7	Impaired glymphatic function and clearance of tau in an Alzheimer’s disease modelbreakdown → 2020 ·Brain ·Ian F. Harrison,Ozama Ismail,Asif Machhada,Niall Colgan,Yolanda Ohene,Payam Nahavandi,Zeshan Ahmed,Alice Fisher,S. Meftah,Tracey K. Murray,Ole Petter Ottersen,Erlend A. Nagelhus,Michael J. O’Neill,Jack A. Wells,Mark F. Lythgoe	403
8	L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils 2020 ·PLoS ONE ·Anna Migdalska‐Richards,Michał Węgrzynowicz,Ian F. Harrison,Guglielmo Verona,Vittorio Bellotti,Maria Grazia Spillantini,Anthony H.V. Schapira	24
9	Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia 2019 ·Acta Neuropathologica Communications ·Ian F. Harrison,(unknown),(unknown),James M. O’Callaghan,Lajos Csincsik,Martina Bocchetta,Da Ma,Alice Fisher,Zeshan Ahmed,Tracey K. Murray,Michael J. O’Neill,Jonathan D. Rohrer,Mark F. Lythgoe,Imre Lengyel	18
10	Imaging of X-Ray-Excited Emissions from Quantum Dots and Biological Tissue in Whole Mouse 2019 ·Scientific Reports ·Sean G. Ryan,(unknown),(unknown),(unknown),P. Stephen Patrick,May Zaw Thin,Ian F. Harrison,Daniel J. Stuckey,Martin Pulé,Mark F. Lythgoe	15
11	Non-invasive imaging of CSF-mediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRI 2018 ·eLife ·Ian F. Harrison,Bernard Siow,(unknown),(unknown),Ozama Ismail,Yolanda Ohene,Payam Nahavandi,David L. Thomas,Mark F. Lythgoe,Jack A. Wells	128
12	Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling: an aquaporin-4 study 2018 ·NeuroImage ·Yolanda Ohene,Ian F. Harrison,Payam Nahavandi,Ozama Ismail,(unknown),Ole Petter Ottersen,Erlend A. Nagelhus,David L. Thomas,Mark F. Lythgoe,Jack A. Wells	115
13	Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease 2017 ·NeuroImage ·J.M. O'Callaghan,Holly E. Holmes,Nick Powell,Jack A. Wells,Ozama Ismail,Ian F. Harrison,Bernard Siow,Ross A. Johnson,Zubair Ahmed,Abraham Fisher,S. Meftah,(unknown),Tracey K. Murray,Emily C. Collins,Karin Shmueli,Mark F. Lythgoe	43
14	Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition 2017 ·Neuroscience Letters ·Ian F. Harrison,Andrew D. Smith,David T. Dexter	82
15	Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy 2017 ·Frontiers in Neuroinformatics ·Holly E. Holmes,Nick Powell,Da Ma,Ozama Ismail,Ian F. Harrison,Jack A. Wells,Niall Colgan,James M. O’Callaghan,Ross A. Johnson,Tracey K. Murray,Zeshan Ahmed,(unknown),Alice Fisher,M. Jorge Cardoso,Marc Modat,Michael J. O’Neill,Emily C. Collins,Elizabeth Fisher,Sébastien Ourselin,Mark F. Lythgoe	39
16	In Vivo Imaging of Tau Pathology Using Magnetic Resonance Imaging Textural Analysis 2017 ·Frontiers in Neuroscience ·Niall Colgan,Balaji Ganeshan,Ian F. Harrison,Ozama Ismail,Holly E. Holmes,Jack A. Wells,Nick Powell,James M. O’Callaghan,Michael J. O’Neill,Tracey K. Murray,Zeshan Ahmed,Emily C. Collins,Ross A. Johnson,Ashley M. Groves,Mark F. Lythgoe	8
17	Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease 2015 ·NeuroImage ·Niall Colgan,Bernard Siow,John M. O’Callaghan,Ian F. Harrison,Jack A. Wells,Holly E. Holmes,Ozama Ismail,Simon Richardson,Daniel C. Alexander,Emily C. Collins,Elizabeth Fisher,Ross A. Johnson,Adam J. Schwarz,Zubair Ahmed,Michael J. O’Neill,Tracey K. Murray,Hui Zhang,Mark F. Lythgoe	154
18	Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate 2015 ·Neuroscience Letters ·Ian F. Harrison,Hiba K. Anis,David T. Dexter	15
19	Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson's disease? 2013 ·Pharmacology & Therapeutics ·Ian F. Harrison,David T. Dexter	179
20	Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease 2012 ·Neurobiology of Aging ·Loukia Katsouri,Marcela P. Vizcaychipi,Simon McArthur,Ian F. Harrison,Marc Suárez‐Calvet,Alberto Lleó,Dafydd G. Lloyd,Daqing Ma,Magdalena Sastre	52

About Ian F. Harrison

Ian F. Harrison is a scholar working on Cellular and Molecular Neuroscience, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Advanced Neuroimaging Techniques and Applications (13 papers), Alzheimer's disease research and treatments (11 papers) and Cerebrospinal fluid and hydrocephalus (11 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (781 citations), Neurology (575 citations) and Neurology (186 citations). Ian F. Harrison has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include David T. Dexter, Mark F. Lythgoe, Jack A. Wells, Ozama Ismail, Yolanda Ohene, Payam Nahavandi, Tracey K. Murray, Michael J. O’Neill, Erlend A. Nagelhus and Niall Colgan. Their work appears in journals such as Nature Communications, PLoS ONE and NeuroImage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact